Building Your Care Team and Managing Daily Life
At a Glance
Children with D-2-HGA benefit from a coordinated care team led by metabolic genetics, with neurology and cardiology support when needed. Individualized heart and brain monitoring, developmental therapies, seizure tracking, and a school emergency plan help families manage daily care safely.
Managing an ultra-rare condition like D-2-hydroxyglutaric aciduria (D-2-HGA) requires a specialized “home base” for your child’s medical care. Because the condition affects multiple systems—the brain, the heart, and the body’s chemistry—you will need a multidisciplinary team that communicates frequently [1][2].
Building Your Specialist Team
While your local pediatrician remains the expert on “typical” childhood concerns (like ear infections or growth), you will need a core group of specialists at a metabolic center of excellence to manage the D-2-HGA.
- Metabolic Geneticist (or Biochemical Geneticist): This is the captain of your team. They interpret the complex laboratory results, monitor your child’s chemistry, and manage any targeted treatments [3][4].
- Pediatric Neurologist: Because seizures, developmental delays, and muscle tone (hypotonia) are common, a neurologist will oversee seizure medications and monitor brain development [5][6].
- Pediatric Cardiologist: This is particularly critical for Type 2 D-2-HGA. They monitor for dilated cardiomyopathy (heart weakening) and arrhythmias (irregular heartbeats) [6][7].
Long-Term Monitoring Schedule
Since D-2-HGA is so rare, there is no “one-size-fits-all” schedule. Your team will create a personalized plan based on your child’s type and symptoms.
Cardiac Surveillance (Heart)
In Type 2 especially, the heart requires careful attention because D-2HG can impact the heart muscle [8].
- Individualized Evaluation: The treating cardiologist may choose to perform baseline evaluations like an echocardiogram (ultrasound) and ECG (heart rhythm test) based on genotype, symptoms, prior results, and treatment [6]. Repeat imaging intervals are individualized, and it is important to remember that a normal test does not eliminate future risk [7].
Neurological Surveillance (Brain)
Neurological monitoring focuses on function rather than just imaging.
- Seizure Review: Regular visits to check if current medications are working or if new “spells” are appearing [5].
- Developmental Tracking: Your team should assess four key areas at every visit: gross motor (walking/sitting), fine motor (grasping), language, and socialization [6].
- Symptom-Triggered Imaging: Routine brain imaging is individualized by your treating neurologist rather than implied for every child. A rare reported association with Moyamoya syndrome exists, but evidence is case-based and does not establish a universal screening program [9]. However, any new, brief focal symptoms (like one-sided weakness) require an immediate call to emergency services.
Day-to-Day Management
Life with D-2-HGA involves balancing medical needs with everyday childhood activities.
- Developmental Therapies: Physical Therapy (PT), Occupational Therapy (OT), and Speech Therapy are the “work” of childhood for many with D-2-HGA. These therapies help build strength and communication skills [6].
- Seizure Management: If your child has epilepsy, keep a simple log of the date, time, and appearance of seizures. This is more helpful to your doctor than a general memory of “a few seizures last week” [6].
- The School Team: Ensure your child’s school has a copy of their Emergency Protocol. This letter, written by your metabolic and cardiology teams, specifies what to do, what not to do, medication and seizure rescue instructions, and when to call emergency services [6][10]. Because excess fluid can worsen heart failure in a child with cardiomyopathy, the letter should not recommend generic “aggressive hydration,” but must contain safe, patient-specific fluid plans.
Advocating for Your Child
You are the only person who sees your child every day. If you feel a “spell” is different from a typical seizure, or if your child seems more tired than usual during physical play, trust your intuition. In the world of ultra-rare disease, your observations are as vital to the care team as a laboratory test [1][11]. Every specialist visit is an opportunity to update the team on these subtle changes and ensure the surveillance plan still fits your child’s needs.
Common questions in this guide
Which specialists should care for a child with D-2-HGA?
How is the heart monitored in D-2-HGA?
What should a school emergency plan include for a child with D-2-HGA?
What therapies may help a child with D-2-HGA?
When is a new neurological symptom an emergency?
How can parents track seizures and changes in daily life?
Get notified when new evidence is published on D-2-hydroxyglutaric aciduria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
I've Never Heard of This! An Approach to Child and Family-Centred Care for Children and Young People With Rare Diseases.
Ewans LJ, Pierce K, Farley E, et al.
Journal of paediatrics and child health 2025; doi:10.1111/jpc.70267.
PMID: 41431132 - 2
Clouds over IMD? Perspectives for inherited metabolic diseases in adults from a retrospective cohort study in two Swiss adult metabolic clinics.
Gariani K, Nascimento M, Superti-Furga A, Tran C
Orphanet journal of rare diseases 2020; (15(1)):210 doi:10.1186/s13023-020-01471-z.
PMID: 32811506 - 3
Diagnostic approach in adult-onset neurometabolic diseases.
Fernández-Eulate G, Carreau C, Benoist JF, et al.
Journal of neurology, neurosurgery, and psychiatry 2022; (93(4)):413-421 doi:10.1136/jnnp-2021-328045.
PMID: 35140137 - 4
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
Reid ES, Papandreou A, Drury S, et al.
Brain : a journal of neurology 2016; (139(11)):2844-2854 doi:10.1093/brain/aww221.
PMID: 27604308 - 5
Acute myeloid leukemia and dilated cardiomyopathy in a pediatric patient with D-2-hydroxyglutaric aciduria type I.
Murphey K, George PE, Pencheva B, et al.
American journal of medical genetics. Part A 2022; (188(9)):2707-2711 doi:10.1002/ajmg.a.62891.
PMID: 35785415 - 6
Enasidenib-induced hepatitis in an individual with Type II D2-hydroxyglutaric aciduria.
Gold JI, Stefanatos AK, Fraser JL, et al.
JIMD reports 2024; (65(3)):156-162 doi:10.1002/jmd2.12421.
PMID: 38736636 - 7
Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation.
Geoerger B, Schiff M, Penard-Lacronique V, et al.
Nature medicine 2023; (29(6)):1358-1363 doi:10.1038/s41591-023-02382-9.
PMID: 37248298 - 8
Disruption of mitochondrial bioenergetics, calcium retention capacity and cell viability caused by D-2-hydroxyglutaric acid in the heart.
Ribeiro RT, Roginski AC, Marschner RA, et al.
Biochimie 2023; (207()):153-164 doi:10.1016/j.biochi.2022.11.004.
PMID: 36372308 - 9
Moyamoya syndrome in a patient with D-2-hydroxyglutaric aciduria type II: a rare association.
Kühnl T, Januschek E, Offenbach SK
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2024; (40(7)):2241-2244 doi:10.1007/s00381-024-06340-9.
PMID: 38668906 - 10
Sweet ending: When genetics prevent a dramatic CDG diagnostic mistake.
Civit A, Gueguen P, Blasco H, et al.
Clinica chimica acta; international journal of clinical chemistry 2023; (551()):117620 doi:10.1016/j.cca.2023.117620.
PMID: 38375626 - 11
Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases.
Gedikbasi A, Toksoy G, Karaca M, et al.
Frontiers in genetics 2023; (14()):1191159 doi:10.3389/fgene.2023.1191159.
PMID: 37377599
This page is for informational purposes only and does not constitute medical advice. Your child’s metabolic, neurology, cardiology, and primary care teams should set the individualized monitoring, emergency, fluid, and seizure plan.